| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.92B | -10.8% |
| R&D Expense | $108.0M | -12.2% |
| Operating Income | $756.0M | -19.4% |
| Pre-tax Income | $554.0M | -25.0% |
| Income Tax | $97.0M | -48.7% |
| Net Income | $431.0M | -14.8% |
| EPS (Basic) | $5.96 | -14.0% |
| EPS (Diluted) | $5.93 | -12.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $987.0M | +7.8% |
| Accounts Receivable | $1.23B | -2.1% |
| Inventory | $836.0M | -5.0% |
| Current Assets | $3.37B | -0.9% |
| Total Assets | $5.20B | +0.7% |
| Current Liabilities | $1.54B | -9.4% |
| Long-term Debt | $1.42B | -10.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $676.0M | -14.6% |
| Capital Expenditures | $226.0M | -24.4% |
| Investing Cash Flow | -$145.0M | +50.5% |
| Financing Cash Flow | -$474.0M | +7.2% |
| Free Cash Flow | $450.0M | -8.7% |
| Total Liabilities |
| $3.50B |
| -9.7% |
| Stockholders' Equity | $1.70B | +32.2% |